TABLE 1

Prevalence (95% CI) of resistance to anti-tuberculosis (TB) drugs in the Philippines

Resistance patternPatient group
NewPreviously treatedRifampicin susceptibleRifampicin resistant
Rifampicin-resistant TB2.6% (1.8–3.3%)29.1% (20.0–38.2%)
Multidrug-resistant TB2.0% (1.4–2.7%)21.3% (15.5–28.7%)
Pyrazinamide0.7% (0.2–1.2%)6.7% (1.3–2.0%)0.4% (0–0.9%)7.2% (1.1–13.4%)
Fluoroquinolone0.1% (0–0.4%)0.1% (0–4.2%)0% (0–0.4%)0% (0–4.6%)
Any second-line injectable#1.5% (0.9–2.2%)1.1% (0–2.7%)1.1% (0.5–1.6%)5.9% (1.6–10.1%)

#: includes kanamycin, capreomycin and amikacin.